Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Yarrow Bioscience, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- 0 vs. Q3 2022
- Shares held
- 7.35M
- −910.6K (−11.0%) vs. Q3 2022
- Total value
- $1.10M
- −$737.7K (−40.1%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 4
- 16 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,650,607 | $247.6K | 0.00% | +1,118+0.1% | Added |
| DSC Advisors, L.P. | 1,570,000 | $235.5K | 0.54% | −1,100,000−41.2% | Reduced |
| BlackRock Inc. | 885,833 | $132.9K | 0.00% | −1,480−0.2% | Reduced |
| Renaissance Technologies LLC | 866,827 | $130.0K | 0.00% | −62,177−6.7% | Reduced |
| Millennium Management LLC | 488,012 | $73.0K | 0.00% | +289,298+145.6% | Added |
| Geode Capital Management, LLC | 449,085 | $67.0K | 0.00% | −1,118−0.2% | Reduced |
| State Street Corp | 210,046 | $31.5K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 135,395 | $20.3K | 0.00% | 00.0% | Unchanged |
| Mackenzie Financial Corp | 134,920 | $20.2K | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 115,000 | $17.3K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 96,134 | $14.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 89,472 | $13.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 88,808 | $13.3K | 0.00% | +130+0.1% | Added |
| Beacon Pointe Advisors, LLC | 74,000 | $11.1K | 0.00% | −1,000−1.3% | Reduced |
| Staley Capital Advisers Inc | 62,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 54,674 | $8.20K | 0.00% | +44,217+422.8% | Added |
| Citadel Advisors LLC | 53,954 | $8.09K | 0.00% | −32,658−37.7% | Reduced |
| Thrivent Financial for Lutherans | 55,064 | $8.00K | 0.00% | 00.0% | Unchanged |
| Deltec Asset Management LLC | 30,000 | $4.50K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 25,811 | $4.00K | 0.00% | −1,471−5.4% | Reduced |
| Bank of New York Mellon Corp | 26,626 | $3.99K | 0.00% | 00.0% | Unchanged |
| CSS LLC | 24,131 | $3.62K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 23,347 | $3.50K | 0.00% | −300−1.3% | Reduced |
| Two Sigma Securities, LLC | 18,901 | $2.83K | 0.00% | +18,901 | New |
| MB, Levis & Associates, LLC | 18,750 | $2.81K | 0.00% | +18,750 | New |
| Jane Street Group, LLC | 18,469 | $2.77K | 0.00% | −32,158−63.5% | Reduced |
| LPL Financial LLC | 16,912 | $2.54K | 0.00% | −400−2.3% | Reduced |
| Susquehanna International Group, LLP | 16,484 | $2.47K | 0.00% | −8,444−33.9% | Reduced |
| StoneX Group Inc. | 13,837 | $2.08K | 0.00% | +13,837 | New |
| Mariner, LLC | 12,500 | $2.00K | 0.00% | −1,462−10.5% | Reduced |
| Tobias Financial Advisors, Inc. | 11,000 | $1.65K | 0.00% | +11,000 | New |
| Russell Investments Group, Ltd. | 3,375 | $506 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 2,557 | $383 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,295 | $344 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,565 | $235 | 0.00% | −990−38.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 875 | $131 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 630 | $95 | 0.00% | −450−41.7% | Reduced |
| Investors Research Corp | 150 | $23 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 171 | $0 | 0.00% | −10−5.5% | Reduced |
| Royal Bank of Canada | 774 | $0 | 0.00% | +129+20.0% | Added |
| Rockefeller Capital Management L.P. | 64 | $0 | 0.00% | −1,300−95.3% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −61,464−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |